NJ attorney general sues opioid company over marketing

Posted: Updated:
NEWARK -

New Jersey Attorney General Gurbir Grewal announced that the state is suing pharmaceutical company Janssen due to claims that the company misled its customers when it to comes to opioids.

The lawsuit is about the drugs Nucynta and Nucynta ER. Grewal claims that the company, which is owned by Johnson and Johnson, engaged in a long list of deceptive practices to increase sales of the drugs. The attorney general says that the company committed fraud in its marketing of the two opioid drugs.

RELATED: NJ drug rehab center to receive $4M grant to fight addiction
RELATED: New Jersey hospital group develops alternative to opioid program

“They funded bogus research. They pushed bogus theories like pseudo-addiction, things that have been debunked. They position Nucynta and Nucynta ER as a safer alternative to other, more powerful opioid drugs…when in fact they were the same types of opioid drugs,” Grewal said.

Janssen sold the rights to both drugs in 2015 for $1 billion. The attorney general is looking to get back some of that money calling it “ill-gotten gains.”

News 12 New Jersey reached out to Janssen for comment, but did not hear back.

sorry to interrupt
your first 20 are free
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please enjoy 20 complimentary views of articles, photos, and videos during the next 30 days.
you have reached your 20 view limit
Access to News 12 is free for Optimum, Comcast®, Spectrum Networks® and Service ElectricSM customers.
Please login or create an account to continue enjoying News12.
Our sign-up page is undergoing maintenance and is not currently available. However, you will be given direct access to news12.com while we complete our upgrade.
When we are back up and running you will be prompted at that time to complete your sign in. Until then, enjoy the local news, weather, traffic and more that's "as local as local news gets."